Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders
作者:Aimo Kannt、Sridharan Rajagopal、Mahanandeesha S. Hallur、Indu Swamy、Rajendra Kristam、Saravanakumar Dhakshinamoorthy、Joerg Czech、Gernot Zech、Herman Schreuder、Sven Ruf
DOI:10.3390/molecules26040991
日期:——
Its expression in several cancer cell lines has been widely discussed in the literature, and recent work established a link between NNMT expression and metabolic diseases. Here we describe our approach to identify potent small molecule inhibitors of NNMT featuring different binding modes as elucidated by X-ray crystallographic studies.
烟酰胺-N-甲基转移酶(NNMT)是催化从S-腺苷甲硫氨酸(SAM)到烟酰胺(Nam)的甲基转移的胞质酶。它在包括肝脏,脂肪组织和骨骼肌在内的许多组织中表达。其在几种癌细胞系中的表达已在文献中进行了广泛讨论,最近的工作建立了NNMT表达与代谢性疾病之间的联系。在这里,我们描述了我们的方法,以鉴定具有不同结合模式的NNMT的有效小分子抑制剂,如X射线晶体学研究所阐明的那样。